How big is the Antifungal Drugs Market?

The Antifungal Drugs Market size is expected to reach USD 16.61 billion in 2024 and grow at a CAGR of 3.9% to reach USD 20.11 billion by 2029. Read More

What is the current Antifungal Drugs Market size?

In 2024, the Antifungal Drugs Market size is expected to reach USD 16.61 billion. Read More

Who are the key players in Antifungal Drugs Market?

Abbott Laboratories, Bayer AG, Merck & Co., Inc., Glenmark Pharmaceuticals Limited and GSK plc are the major companies operating in the Antifungal Drugs Market. Read More

Which is the fastest growing region in Antifungal Drugs Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029). Read More

Which region has the biggest share in Antifungal Drugs Market?

In 2024, the North America accounts for the largest market share in Antifungal Drugs Market. Read More

What years does this Antifungal Drugs Market cover, and what was the market size in 2023?

In 2023, the Antifungal Drugs Market size was estimated at USD 15.96 billion. The report covers the Antifungal Drugs Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Antifungal Drugs Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029. Read More

Antifungal Drugs Market Share

Statistics for the 2023 & 2024 Antifungal Drugs market share, created by Mordor Intelligence™ Industry Reports. Antifungal Drugs share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Market Share of Antifungal Drugs Industry

The analyzed market is fragmented, primarily due to the presence of a limited number of smaller players and several major industry players. The market participants are actively engaged in launching new products and obtaining approvals for them, which is anticipated further to intensify the competitive environment within the studied market. Among the significant market players are Abbott Laboratories, Bayer AG, Astellas Pharma Inc., Glenmark Pharmaceuticals Limited, GSK PLC, Merck & Co. Inc., Novartis AG, and Pfizer Inc.